IDEXX 연구소, Inc.
DE ˙ XTRA ˙ US45168D1046
€490.30 ↑19.90 (4.23%)
2026-06-04
주가
SecurityDE:IX1 / IDEXX Laboratories, Inc.
InstitutionEmpowered Funds, LLC
Latest Disclosed Ownership4,172 shares
Latest Disclosed Value $ 2,344,206
Empowered Funds, LLC reports 65.68% decrease in ownership of IX1 / IDEXX Laboratories, Inc.

On May 15, 2026 - Empowered Funds, LLC filed a 13F-HR form disclosing ownership of 4,172 shares of IDEXX Laboratories, Inc. (DE:IX1) valued at $2,035,936 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on February 18, 2026 disclosing 12,157 shares of IDEXX Laboratories, Inc.. This represents a change in shares of -65.68% during the quarter. The current value of the position is $2,045,532 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IDEXX LABS COM 45168D104 4,172 -7,985 -65.68 2,344 -71.50 0.0066
2026-02-18 2025-12-31 13F/A-1 IDEXX LABS COM 45168D104 12,157 8,225 209.18 8,225 227.39 0.1396
2026-02-11 2025-12-31 13F IDEXX LABS COM 45168D104 12,157 8,225 8,225 0.0160
2025-11-13 2025-09-30 13F IDEXX LABS COM 45168D104 3,932 2,103 114.98 2,512 156.33 0.0254
2025-08-11 2025-06-30 13F IDEXX LABS COM 45168D104 1,829 291 18.92 981 51.94 0.0111
2025-05-16 2025-03-31 13F IDEXX LABS COM 45168D104 1,538 95 6.58 646 8.22 0.0092
2025-01-28 2024-12-31 13F IDEXX LABS COM 45168D104 1,443 133 10.15 597 -9.83 0.0087
2024-11-06 2024-09-30 13F IDEXX LABS COM 45168D104 1,310 36 2.83 662 6.61 0.0104
2024-07-30 2024-06-30 13F IDEXX LABS COM 45168D104 1,274 235 22.62 621 10.71 0.0107
2024-05-07 2024-03-31 13F/A-1 IDEXX LABS COM 45168D104 1,039 227 27.96 561 24.44 0.0101
2024-05-06 2024-03-31 13F IDEXX LABS COM 45168D104 1,039 227 561 0.0048
2024-02-14 2023-12-31 13F IDEXX LABS COM 45168D104 812 120 17.34 451 49.01 0.0113
2023-11-01 2023-09-30 13F IDEXX LABS COM 45168D104 692 138 24.91 303 8.63 0.0089
2023-07-27 2023-06-30 13F IDEXX LABS COM 45168D104 554 554 278 0.0098
2018-07-09 2017-09-30 13F/A-1 IDEXX LABS COM 45168D104 0 -4,096 -100.00 0 -100.00
2018-07-09 2017-06-30 13F/A-1 IDEXX LABS COM 45168D104 4,096 4,096 661 0.5360
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.